Why GHK-Cu Alone Often Underperforms in Deep Injury Recovery GHK-Cu can be impressive in skin quality and surface-level regeneration, yet deep tissue injuries and chronic inflammatory issues often require more groundwork
Selected Data 1) This comprehensive study performed by the research team of McCoy et al aimed to develop metabolically stable AngIV analogs with enhanced blood-brain barrier (BBB) permeability and procognitive activity, specifically focusing on a molecule named Dihexa
But why, I ask, are there no gold-standard trials on humans
We recommend cycling Dihexa (e.g., 90 days on, 30 days off) and avoiding indefinite use
Kirke SM, Lowder S, Lloyd JJ, Diffey BL, Matthews JN, Farr PM
Responses to medications can differ greatly based on factors such as metabolic characteristics, tolerability, lifestyle, and personal preferences